Keros Therapeutics Initiates Phase 3 Trial of Elritercept for MDS

Keros Therapeutics announced the first patient dosing in the Phase 3 RENEW clinical trial of elritercept for adults with transfusion-dependent anemia ...
Home/KnloSights/Clinical Trial Updates/Keros Therapeutics Initiates Phase 3 Trial of Elritercept for MDS